No. The HHS 'Wolves in White Coats' report is a politically commissioned document produced under the Trump administration, not an independent peer-reviewed investigation. Its fraud claims rest on misreading standard medical billing codes. Gender-affirming care has decades of outcome evidence behind it, endorsed by every major international medical body.
What is the 'Wolves in White Coats' report?
In early 2025, the United States Department of Health and Human Services published a document titled "Protecting Children from Chemical and Surgical Mutilation," later circulated under the 'Wolves in White Coats' label. It was produced inside a federal department whose leadership had already, publicly and repeatedly, committed to ending gender-affirming care for minors. That is the first thing to understand: the conclusion came before the investigation. A report commissioned to justify a policy already decided is not the same as research designed to test whether that policy is correct.
No independent scientific body peer-reviewed the document. No external ethics board assessed its methodology. It was not published in a journal, did not go through a process of academic scrutiny, and its authors were not a panel of gender medicine specialists assembled to weigh competing evidence. It was an internal government document produced to support an executive agenda, and it should be read as such.
What does the report actually claim?
The report makes several overlapping claims: that gender-affirming care is experimental and unsupported by evidence, that clinicians have committed billing fraud by using codes designed for precocious puberty to bill for gender-related care, and that children are being sterilised and permanently harmed through deliberate deception by medical providers.
These are serious allegations. They deserve serious examination, which is exactly what they have not received from the people making them.
The billing code argument does not hold up
The centrepiece of the fraud claim is the observation that billing codes used for puberty blocker prescriptions in trans young people are the same codes used when puberty blockers are given for precocious puberty, a condition where puberty begins far earlier than it should, sometimes in children as young as six or seven. The report treats this shared coding as evidence of deception: clinicians are disguising gender-related prescriptions as something more medically conventional to evade scrutiny or insurance restrictions.
This argument misunderstands how medical billing works. Billing codes describe what a drug does physiologically, not the clinical context in which it is being used. A GnRH agonist pauses the hormonal cascade that drives puberty. That is what it does, whether the child receiving it has precocious puberty or gender dysphoria. The code follows the mechanism, not the diagnosis. Clinicians using a precocious-puberty code for a puberty blocker prescription are using the code that accurately describes what is happening in the body. That is correct coding, not fraud.
To describe this as deceptive requires either a misunderstanding of medical coding conventions or a decision to misrepresent them. Neither is a foundation for a fraud allegation that, in the report's framing, extends to the entire field of gender medicine.
The sterilisation claim
The report repeatedly uses the word sterilisation to describe the effect of gender-affirming care. This framing deserves careful attention because it is doing a great deal of political work in a very small space.
Puberty blockers, as the name says, pause puberty. They do not remove reproductive organs. They do not permanently alter fertility in themselves. A young person who stops taking puberty blockers will resume the puberty their body would otherwise have followed. The fertility question becomes more complex if that person then proceeds to cross-sex hormone therapy, and clinicians working in this field discuss that with young people and their families as part of the consent process. That is what informed consent looks like: naming what is known, naming what is not yet known, and supporting the person and their family to weigh it.
Calling that process sterilisation is not a clinical description. It is a rhetorical choice designed to produce a particular emotional response. I have spent a long time listening to trans young people talk about their bodies and their futures, and the picture that emerges is not of children being deceived about what treatment involves. It is of young people who understand very clearly what they want, who often know more about their options than the adults around them, and who are navigating a system that asks them to prove their own identities over and over before it will help them.
What does the evidence actually say?
Gender-affirming care is not experimental in any meaningful clinical sense. GnRH agonists have been used in medicine for decades, first in precocious puberty, and the physiological effects are well understood. Cross-sex hormone therapy has a substantial outcome literature. The WPATH Standards of Care, now in their eighth edition, represent the accumulated clinical knowledge of specialists who have spent careers in this field. The Endocrine Society has published detailed clinical guidelines. The American Academy of Pediatrics supports access to gender-affirming care, a position it reaffirmed in 2025 directly in response to federal pressure. The World Health Organisation, the American Medical Association, the American Psychological Association, and the World Medical Association all sit in the same place.
The research literature is not perfect, because no area of medicine has a perfect literature, and anyone who tells you otherwise about their own specialism is not being straight with you. What the literature does show, consistently, is that gender-affirming care is associated with improved mental health outcomes, reduced rates of suicidal ideation, and better quality of life for trans young people. The studies have different designs and different sample sizes and they are not all equally strong. That is true of every area of paediatric medicine. It does not make them evidence of fraud.
The Cass Review and the international response
The report draws on a body of literature that includes work associated with the Society for Evidence-Based Gender Medicine, SEGM, a network whose published positions and funding have been widely examined and criticised by gender medicine researchers. The Cass Review, a UK report that drew heavily on similar sources and similarly restricted the evidence it was willing to consider, has been internationally discredited. Detailed rebuttals have been published by gender medicine experts across multiple countries. Citing these sources as independent scientific validation is not the same as having independent scientific validation.
There is a pattern here that is worth naming. A small number of researchers and advocacy organisations have produced a body of work that questions gender-affirming care, and that work is then cited, by itself, as the scientific consensus, while the much larger body of affirming research is framed as ideologically compromised. This is not how scientific weight works. The number of major medical bodies that have reviewed the evidence and reached the same affirming conclusion is not explained away by accusing all of them of ideology.
Why does this report matter even if it is wrong?
Because policy follows it. In the United States, this document has been used to justify executive orders, funding restrictions, and state-level bans on care. In practice, that means young people who needed help are not getting it, families who wanted to support their children have had that support blocked, and clinicians who were providing evidence-based care have been placed under threat of prosecution. The harm from withholding care is not theoretical. Unwanted puberty produces permanent physical changes. Every month a young person waits is a month of a puberty they did not want and cannot undo. A document that accelerates that wait, whatever its stated intentions, is causing harm to real children.
Describing a political report as fraudulent science is not a neutral act. Neither is treating it as settled proof. The people who pay the price for that confusion are not the commentators sharing the report on social media. They are trans young people, and the adults who love them, trying to navigate a healthcare system that has been deliberately made harder to access.
How to read documents like this
When a government publishes a document that looks like research, ask who commissioned it and when the commission was issued relative to the policy it supports. Ask whether it went through peer review. Ask who the authors are and whether their professional background is in the field they are assessing. Ask whether the sources it cites are from the mainstream literature or from a small network of like-minded researchers citing each other. Ask whether the conclusions were announced before the evidence was gathered.
The 'Wolves in White Coats' report does not survive those questions. That does not mean every concern about gender-affirming care is in bad faith, or that the field has no room to improve, or that clinical standards should not keep developing. It means this particular document is not evidence of fraud. It is evidence of a political administration using the machinery of government to produce the appearance of scientific authority for a conclusion it had already reached.
If there is a topic that you would like me to cover, just let Sammy know.
Dr Helen Webberley is a gender specialist, medical educator, and founder of GenderGP. She writes about gender identity, trans healthcare, and the fight for equality.
Comments